Home › Funds › Deep Track Capital, LP › MBX

Deep Track Capital, LP position in MBX

MBX BIOSCIENCES INC · Health Care

Deep Track Capital, LP reported holding 640,000 shares of MBX (MBX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$37.5M, representing 0.63% of its reported portfolio and ranking #44 among its reported holdings. Deep Track Capital, LP has disclosed MBX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)640.00K sh
Reported value held$37.52M
Portfolio Weight0.63%
First reportedQ3 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's MBX position evolved

Deep Track Capital, LP first disclosed a stake in MBX in Q3 2024 at 3,018,935 shares (US$78.4M). The position peaked in Q4 2025 at 3,249,790 shares, worth US$102.5M. Across 9 filings, Deep Track Capital, LP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 640,000 shares valued at US$37.5M — a reduction of -1,092,569 shares quarter over quarter.. Notable position changes include a 44% increase in Q3 2025 (shares rose 80% over the following quarter), a 37% trim in Q2 2026 (shares rose 6% over the following quarter), a 63% trim in Q3 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.02M $78.43M New
Q4 2024 3.02M $55.64M Hold
Q1 2025 3.02M $22.28M Hold
Q2 2025 2.19M $24.97M Reduce
Q3 2025 3.15M $55.12M Add
Q4 2025 3.25M $102.50M Add
Q1 2026 2.76M $82.31M Reduce
Q2 2026 1.73M $95.64M Reduce
Q3 2026 640.00K $37.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MBX and 13F data

MBX (MBX BIOSCIENCES INC) is a Health Care company. 61 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), Paradigm Biocapital Advisors LP (US$221.2M), NEA Management Company, LLC (US$199.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has Deep Track Capital, LP held MBX?

Deep Track Capital, LP has disclosed MBX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Deep Track Capital, LP's current position in MBX?

As of Q3 2026, Deep Track Capital, LP holds 640.00K shares of MBX (MBX BIOSCIENCES INC), valued at $37.52M, representing 0.63% of its reported portfolio and ranking #44.

Has Deep Track Capital, LP been buying or selling MBX?

In the latest 13F filing (Q3 2026), Deep Track Capital, LP reduced its position in MBX. The position peaked in Q4 2025 at 3.25M shares.

Which other funds hold MBX?

Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, NEA Management Company, LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.